Lexaria Bioscience (LEXX) Prepaid Assets (2011 - 2026)
Lexaria Bioscience's (LEXX) quarterly Prepaid Assets came in at $458846.0 in Q1 2026, down 46.04% year-on-year from $850387.0 in Q1 2025, and down 46.06% quarter-over-quarter from $850585.0 in Q4 2025.
Lexaria Bioscience (LEXX) Prepaid Assets (2011 - 2026) Analysis & Trends
Lexaria Bioscience has disclosed Prepaid Assets across 16 years of filings, most recently posting $458846.0 for Q1 2026.
- Prepaid Assets for Q1 2026 came in at $458846.0, down 46.04% year-over-year; the trailing twelve-month figure through Feb 2026 was $458846.0 (down 46.04% YoY), and the FY2025 annual result was $1.1 million, down 4.66% from the prior year.
- Prepaid Assets came in at $458846.0 for Q1 2026 at Lexaria Bioscience, down from $850585.0 in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $1.2 million in Q3 2024 to a low of $132311.0 in Q4 2023.
- The 5-year median for Prepaid Assets is $576761.0 (2022), against an average of $631691.0.
- Across the five-year window, Prepaid Assets jumped 344.33% in 2022 and slumped 71.51% in 2023, its largest moves.
- Lexaria Bioscience's Prepaid Assets stood at $260342.0 in 2022, then plunged by 49.18% to $132311.0 in 2023, then soared by 235.66% to $444121.0 in 2024, then soared by 91.52% to $850585.0 in 2025, then plunged by 46.06% to $458846.0 in 2026.
- The last three Prepaid Assets figures came in at $458846.0 (Q1 2026), $850585.0 (Q4 2025), and $1.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Lexaria Bioscience | 7.17 Mn | 1.65 Mn | 20,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 458,846.00 |
| Nov 30, 2025 | 850,585.00 |
| Aug 31, 2025 | 1.13 Mn |
| May 31, 2025 | 823,348.00 |
| Feb 28, 2025 | 850,387.00 |
| Nov 30, 2024 | 444,121.00 |
| Aug 31, 2024 | 1.19 Mn |
| May 31, 2024 | 379,546.00 |
| Feb 29, 2024 | 266,796.00 |
| Nov 30, 2023 | 132,311.00 |
| Aug 31, 2023 | 546,783.00 |
| May 31, 2023 | 629,740.00 |
| Feb 28, 2023 | 319,591.00 |
| Nov 30, 2022 | 260,342.00 |
| Aug 31, 2022 | 576,761.00 |
| May 31, 2022 | 757,308.00 |
| Feb 28, 2022 | 1.12 Mn |
| Nov 30, 2021 | 237,223.00 |
| Aug 31, 2021 | 319,253.00 |
| May 31, 2021 | 170,439.00 |